The Role of Machine Learning and Deep Learning Approaches for the Detection of Skin Cancer

Proteoglycan-degrading enzymes engineered for enhanced tumor microenvironment interaction in renal cell carcinoma

This work optimized proteoglycan-degrading enzymes through targeted mutagenesis to enhance their interaction with the tumor microenvironment in Renal Cell Carcinoma (RCC). A comprehensive mutagenesis approach identified 60 key mutations significantly improving enzymatic activity, stability, and structural integrity. When compared to Wild Type (WT) enzyme, a remarkable increase in specific activity by 35 % (p < 0.001) and a considerable decrease in the Km values for hyaluronidases from 2.5 mM to 1.5 mM (p < 0.05), as a result of these modifications. Computational methods are then employed to analyze the active site of the enzymes to detect potential residues that may alter. These computational techniques include molecular docking and protein structure prediction. The structural models of the enzymes are created by utilizing homology modeling and crystallography. These models demonstrate the spatial arrangement of the amino acid enzymes. It also illustrated the specific mutations to improve the potential of enzymes to relate to the Extracellular Matrix (ECM) of tumors. The computational screening methods effectively predicted how the modifications impact enzyme catalytic efficiency and stability. The modified enzymes retained 85 % of the enzyme activity, while the WT retained 60 %. Thus, the modified enzymes demonstrated better thermal stability than WT. Vitro test analyses show that the proteoglycan breakdown was significantly reduced by 70 % (p < 0.001), and for effective proteoglycan breakdown, hyaluronidase concentration is needed. This work proposed a novel therapeutic approach called proteoglycan-degrading enzymes for the treatment of RCC. These proteoglycan-degrading enzymes are more stable and effective for treating RCC, as demonstrated in the outcomes. Customized proteoglycan-degrading enzymes make the therapy more effective. The effective breakdown of the tumor's ECM in RCC models establishes this customized proteoglycan-degrading enzyme. These enzymes are effective for this customized cancer treatment as they improve stability, activity, and interaction with the TME.

Fractional gradient optimized explainable convolutional neural network for Alzheimer's disease diagnosis

Alzheimer's is one of the brain syndromes that steadily affects the brain memory. The early stage of Alzheimer's disease (AD) is referred to as mild cognitive impairment (MCI), and the growth of Alzheimer's is not certain in patients with MCI. The premature detection of Alzheimer's is crucial for maintaining healthy brain function and avoiding memory loss. Different multi-neural network architectures have been proposed by researchers for efficient and accurate AD detection. The absence of improved feature extraction mechanisms and unexplored efficient optimizers in complex benchmark architectures lead to an inefficient and inaccurate AD classification. Moreover, the standard convolutional neural network (CNN)-based architectures for Alzheimer's diagnosis lack interpretability in their predictions. An interpretable, simplified, yet effective deep learning model is required for the accurate classification of AD. In this study, a generalized fractional order-based CNN classifier with explainable artificial intelligence (XAI) capabilities is proposed for accurate, efficient, and interpretable classification of AD diagnosis. The proposed study (a) classifies AD accurately by incorporating unexplored pooling technique with enhanced feature extraction mechanism, (b) provides fractional order-based optimization approach for adaptive learning and fast convergence speed, and (c) suggests an interpretable method for proving the transparency of the model. The proposed model outperforms complex benchmark architectures with regard to accuracy using standard ADNI dataset. The proposed fractional order-based CNN classifier achieves an improved accuracy of 99 % as compared to the state-of-the-art models.

A hybrid CNN with transfer learning for skin cancer disease detection

The leading cause of cancer-related deaths worldwide is skin cancer. Effective therapy depends on the early diagnosis of skin cancer through the precise classification of skin lesions. However, dermatologists may find it difficult and time-consuming to accurately classify skin lesions. The use of transfer learning to boost skin cancer classification model precision is a promising strategy. In this work, we proposed a hybrid CNN with a transfer learning model and a random forest classifier for skin cancer disease detection. To evaluate the efficacy of the proposed model, it was verified over two datasets of benign skin moles and malignant skin moles. The proposed model is able to classify images with an accuracy of up to 90.11%. The empirical results and analysis assure the feasibility and effectiveness of the proposed model for skin cancer classification.

Detection of real-time deep fakes and face forgery in video conferencing employing generative adversarial networks

As facial modification technology advances rapidly, it poses a challenge to methods used to detect fake faces. The advent of deep learning and AI-based technologies has led to the creation of counterfeit photographs that are more difficult to discern apart from real ones. Existing Deep fake detection systems excel at spotting fake content with low visual quality and are easily recognized by visual artifacts. The study employed a unique active forensic strategy Compact Ensemble-based discriminators architecture using Deep Conditional Generative Adversarial Networks (CED-DCGAN), for identifying real-time deep fakes in video conferencing. DCGAN focuses on video-deep fake detection on features since technologies for creating convincing fakes are improving rapidly. As a first step towards recognizing DCGAN-generated images, split real-time video images into frames containing essential elements and then use that bandwidth to train an ensemble-based discriminator as a classifier. Spectra anomalies are produced by up-sampling processes, standard procedures in GAN systems for making large amounts of fake data films. The Compact Ensemble discriminator (CED) concentrates on the most distinguishing feature between the natural and synthetic images, giving the generators a robust training signal. As empirical results on publicly available datasets show, the suggested algorithms outperform state-of-the-art methods and the proposed CED-DCGAN technique successfully detects high-fidelity deep fakes in video conferencing and generalizes well when comparing with other techniques. Python tool is used for implementing this proposed study and the accuracy obtained for proposed work is 98.23 %.

Alenizi F, Varzeghani AN, Asghari P, Darwesh A, Malik MH, Lee SW. A model for skin cancer using combination of ensemble learning and deep learning

Skin cancer has a significant impact on the lives of many individuals annually and is recognized as the most prevalent type of cancer. In the United States, an estimated annual incidence of approximately 3.5 million people receiving a diagnosis of skin cancer underscores its widespread prevalence. Furthermore, the prognosis for individuals afflicted with advancing stages of skin cancer experiences a substantial decline in survival rates. This paper is dedicated to aiding healthcare experts in distinguishing between benign and malignant skin cancer cases by employing a range of machine learning and deep learning techniques and different feature extractors and feature selectors to enhance the evaluation metrics. In this paper, different transfer learning models are employed as feature extractors, and to enhance the evaluation metrics, a feature selection layer is designed, which includes diverse techniques such as Univariate, Mutual Information, ANOVA, PCA, XGB, Lasso, Random Forest, and Variance. Among transfer models, DenseNet-201 was selected as the primary feature extractor to identify features from data. Subsequently, the Lasso method was applied for feature selection, utilizing diverse machine learning approaches such as MLP, XGB, RF, and NB. To optimize accuracy and precision, ensemble methods were employed to identify and enhance the best-performing models. The study provides accuracy and sensitivity rates of 87.72% and 92.15%, respectively.

Performance evaluation of E-VGG19 model: Enhancing real-time skin cancer detection and classification

Skin cancer is a pervasive and potentially life-threatening disease. Early detection plays a crucial role in improving patient outcomes. Machine learning (ML) techniques, particularly when combined with pre-trained deep learning models, have shown promise in enhancing the accuracy of skin cancer detection. In this paper, we enhanced the VGG19 pre-trained model with max pooling and dense layer for the prediction of skin cancer. Moreover, we also explored the pre-trained models such as Visual Geometry Group 19 (VGG19), Residual Network 152 version 2 (ResNet152v2), Inception-Residual Network version 2 (InceptionResNetV2), Dense Convolutional Network 201 (DenseNet201), Residual Network 50 (ResNet50), Inception version 3 (InceptionV3), For training, skin lesions dataset is used with malignant and benign cases. The models extract features and divide skin lesions into two categories: malignant and benign. The features are then fed into machine learning methods, including Linear Support Vector Machine (SVM), k-Nearest Neighbors (KNN), Decision Tree (DT), Logistic Regression (LR) and Support Vector Machine (SVM), our results demonstrate that combining E-VGG19 model with traditional classifiers significantly improves the overall classification accuracy for skin cancer detection and classification. Moreover, we have also compared the performance of baseline classifiers and pre-trained models with metrics (recall, F1 score, precision, sensitivity, and accuracy). The experiment results provide valuable insights into the effectiveness of various models and classifiers for accurate and efficient skin cancer detection. This research contributes to the ongoing efforts to create automated technologies for detecting skin cancer that can help healthcare professionals and individuals identify potential skin cancer cases at an early stage, ultimately leading to more timely and effective treatments.

Machine learning (ML) techniques as effective methods for evaluating hair and skin assessments: A systematic review

Machine Learning (ML) techniques provide the ability to effectively evaluate and analyze human skin and hair assessments. The aim of this study is to systematically review the effectiveness of applying Machine Learning (ML) methods and Artificial Intelligence (AI) techniques in order to evaluate hair and skin assessments. PubMed, Web of Science, IEEE Xplore, and Science Direct were searched in order to retrieve research publications between 1 January 2010 and 31 March 2020 using appropriate keywords such as "hair and skin analysis." Following accurate screening, 20 peer-reviewed publications were selected for inclusion in this systematic review. The analysis demonstrated that prevalent Machine Learning (ML) methods comprised of Support Vector Machine (SVM), k-nearest Neighbor, and Artificial Neural Networks (ANN). ANN's were observed to yield the highest accuracy of 95% followed by SVM generating 90%. These techniques were most commonly applied for drafting framework assessments such as that of Melanoma. Values of parameters such as Sensitivity, Specificity, and Area under the Curve (AUC) were extracted from the studies and with the help of comparisons, relevant inferences were also made. ANN's were observed to yield the highest sensitivity of 82.30% as well as a 96.90% specificity. Hence, with this systematic review, a summarization of the studies was drafted that encapsulated how Machine Learning (ML) techniques have been employed for the analysis and evaluation of hair and skin assessments.

Skin Lesion Classification and Detection Using Machine Learning Techniques: A Systematic Review

Skin lesions are essential for the early detection and management of a number of dermatological disorders. Learning-based methods for skin lesion analysis have drawn much attention lately because of improvements in computer vision and machine learning techniques. A review of the most-recent methods for skin lesion classification, segmentation, and detection is presented in this survey paper. The significance of skin lesion analysis in healthcare and the difficulties of physical inspection are discussed in this survey paper. The review of state-of-the-art papers targeting skin lesion classification is then covered in depth with the goal of correctly identifying the type of skin lesion from dermoscopic, macroscopic, and other lesion image formats. The contribution and limitations of various techniques used in the selected study papers, including deep learning architectures and conventional machine learning methods, are examined. The survey then looks into study papers focused on skin lesion segmentation and detection techniques that aimed to identify the precise borders of skin lesions and classify them accordingly. These techniques make it easier to conduct subsequent analyses and allow for precise measurements and quantitative evaluations. The survey paper discusses well-known segmentation algorithms, including deep-learning-based, graph-based, and region-based ones. The difficulties, datasets, and evaluation metrics particular to skin lesion segmentation are also discussed. Throughout the survey, notable datasets, benchmark challenges, and evaluation metrics relevant to skin lesion analysis are highlighted, providing a comprehensive overview of the field. The paper concludes with a summary of the major trends, challenges, and potential future directions in skin lesion classification, segmentation, and detection, aiming to inspire further advancements in this critical domain of dermatological research.

MSRNet: Multiclass Skin Lesion Recognition Using Additional Residual Block Based Fine-Tuned Deep Models Information Fusion and Best Feature Selection

Cancer is one of the leading significant causes of illness and chronic disease worldwide. Skin cancer, particularly melanoma, is becoming a severe health problem due to its rising prevalence. The considerable death rate linked with melanoma requires early detection to receive immediate and successful treatment. Lesion detection and classification are more challenging due to many forms of artifacts such as hairs, noise, and irregularity of lesion shape, color, irrelevant features, and textures. In this work, we proposed a deep-learning architecture for classifying multiclass skin cancer and melanoma detection. The proposed architecture consists of four core steps: image preprocessing, feature extraction and fusion, feature selection, and classification. A novel contrast enhancement technique is proposed based on the image luminance information. After that, two pre-trained deep models, DarkNet-53 and DensNet-201, are modified in terms of a residual block at the end and trained through transfer learning. In the learning process, the Genetic algorithm is applied to select hyperparameters. The resultant features are fused using a two-step approach named serial-harmonic mean. This step increases the accuracy of the correct classification, but some irrelevant information is also observed. Therefore, an algorithm is developed to select the best features called marine predator optimization (MPA) controlled Reyni Entropy. The selected features are finally classified using machine learning classifiers for the final classification. Two datasets, ISIC2018 and ISIC2019, have been selected for the experimental process. On these datasets, the obtained maximum accuracy of 85.4% and 98.80%, respectively. To prove the effectiveness of the proposed methods, a detailed comparison is conducted with several recent techniques and shows the proposed framework outperforms.

Computational biology and in vitro studies for anticipating cancer-related molecular targets of sweet wormwood (Artemisia annua)

BACKGROUND

Cancer is one of the leading causes of death worldwide. Recently, it was shown that many natural extracts have positive effects against cancer, compared with chemotherapy or recent hormonal treatments. A. annua is an annual medicinal herb used in the traditional Chinese medicine. It has also been shown to inhibit the proliferation of various cancer cell lines.

METHODS

Multi-level modes of action of A. annua constituents in cancer therapy were investigated using an integrated approach of network pharmacology, molecular docking, dynamic simulations and in-vitro cytotoxicity testing on both healthy and cancer cells.

RESULTS

Network pharmacology-based analysis showed that the hit Artemisia annua constituents related to cancer targets were 3-(2-methylpropanoyl)-4-cadinene-3,11-diol, artemisinin G, O-(2-propenal) coniferaldehyde, (2-glyceryl)-O-coniferaldehyde and arteamisinin III, whereas the main cancer allied targets were NFKB1, MAP2K1 and AR. Sixty-eight significant signaling KEGG pathways with p < 0.01 were recognized, the most enriched of which were prostate cancer, breast cancer, melanoma and pancreatic cancer. Thirty-five biological processes were mainly regulated by cancer, involving cellular response to mechanical stimulus, positive regulation of gene expression and transcription. Molecular docking analysis of the top hit compounds against the most enriched target proteins showed that 3-(2-methylpropanoyl)-4-cadinene-3,11-diol and O-(2-propenal) coniferaldehyde exhibited the most stabilized interactions. Molecular dynamics simulations were performed to explain the stability of these two compounds in their protein-ligand complexes. Finally, confirmation of the potential anticancer activity was attained by in-vitro cytotoxicity testing of the extract on human prostate (PC-3), breast (MDA-MB-231), pancreatic (PANC-1) and melanoma (A375) cancerous cell lines.

CONCLUSION

This study presents deeper insights into A. annua molecular mechanisms of action in cancer for the first time using an integrated approaches verifying the herb's value.

Deep Learning in Diagnosis of Dental Anomalies and Diseases: A Systematic Review

Deep learning and diagnostic applications in oral and dental health have received significant attention recently. In this review, studies applying deep learning to diagnose anomalies and diseases in dental image material were systematically compiled, and their datasets, methodologies, test processes, explainable artificial intelligence methods, and findings were analyzed. Tests and results in studies involving human-artificial intelligence comparisons are discussed in detail to draw attention to the clinical importance of deep learning. In addition, the review critically evaluates the literature to guide and further develop future studies in this field. An extensive literature search was conducted for the 2019-May 2023 range using the Medline (PubMed) and Google Scholar databases to identify eligible articles, and 101 studies were shortlisted, including applications for diagnosing dental anomalies (n = 22) and diseases (n = 79) using deep learning for classification, object detection, and segmentation tasks. According to the results, the most commonly used task type was classification (n = 51), the most commonly used dental image material was panoramic radiographs (n = 55), and the most frequently used performance metric was sensitivity/recall/true positive rate (n = 87) and accuracy (n = 69). Dataset sizes ranged from 60 to 12,179 images. Although deep learning algorithms are used as individual or at least individualized architectures, standardized architectures such as pre-trained CNNs, Faster R-CNN, YOLO, and U-Net have been used in most studies. Few studies have used the explainable AI method (n = 22) and applied tests comparing human and artificial intelligence (n = 21). Deep learning is promising for better diagnosis and treatment planning in dentistry based on the high-performance results reported by the studies. For all that, their safety should be demonstrated using a more reproducible and comparable methodology, including tests with information about their clinical applicability, by defining a standard set of tests and performance metrics.

Diagnosing Melanomas in Dermoscopy Images Using Deep Learning

When it comes to skin tumors and cancers, melanoma ranks among the most prevalent and deadly. With the advancement of deep learning and computer vision, it is now possible to quickly and accurately determine whether or not a patient has malignancy. This is significant since a prompt identification greatly decreases the likelihood of a fatal outcome. Artificial intelligence has the potential to improve healthcare in many ways, including melanoma diagnosis. In a nutshell, this research employed an Inception-V3 and InceptionResnet-V2 strategy for melanoma recognition. The feature extraction layers that were previously frozen were fine-tuned after the newly added top layers were trained. This study used data from the HAM10000 dataset, which included an unrepresentative sample of seven different forms of skin cancer. To fix the discrepancy, we utilized data augmentation. The proposed models outperformed the results of the previous investigation with an effectiveness of 0.89 for Inception-V3 and 0.91 for InceptionResnet-V2.

Amomum subulatum: A treasure trove of anti-cancer compounds targeting TP53 protein using in vitro and in silico techniques

Cancer is a primary global health concern, and researchers seek innovative approaches to combat the disease. Clinical bioinformatics and high-throughput proteomics technologies provide powerful tools to explore cancer biology. Medicinal plants are considered effective therapeutic agents, and computer-aided drug design (CAAD) is used to identify novel drug candidates from plant extracts. The tumour suppressor protein TP53 is an attractive target for drug development, given its crucial role in cancer pathogenesis. This study used a dried extract of Amomum subulatum seeds to identify phytocompounds targeting TP53 in cancer. We apply qualitative tests to determine its phytochemicals (Alkaloid, Tannin, Saponin, Phlobatinin, and Cardic glycoside), and found that alkaloid composed of 9.4% ± 0.04% and Saponin 1.9% ± 0.05% crude chemical constituent. In the results of DPPH Analysis Amomum subulatum Seeds founded antioxidant activity, and then we verified via observing methanol extract (79.82%), BHT (81.73%), and n-hexane extract (51.31%) found to be positive. For Inhibition of oxidation, we observe BHT is 90.25%, and Methanol (83.42%) has the most significant proportion of linoleic acid oxidation suppression. We used diverse bioinformatics approaches to evaluate the effect of A. subulatum seeds and their natural components on TP53. Compound-1 had the best pharmacophore match value (53.92), with others ranging from 50.75 to 53.92. Our docking result shows the top three natural compounds had the highest binding energies (-11.10 to -10.3 kcal/mol). The highest binding energies (-10.9 to -9.2 kcal/mol) compound bonded to significant sections in the target protein's active domains with TP53. Based on virtual screening, we select top phytocompounds for targets which highly fit based on pharmacophore score and observe these compounds exhibited potent antioxidant activity and inhibited cancer cell inflammation in the TP53 pathway. Molecular Dynamics (MD) simulations indicated that the ligand was bound to the protein with some significant conformational changes in the protein structure. This study provides novel insights into the development of innovative drugs for the treatment of cancer disorders.